GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanologica AB (OSTO:NICA) » Definitions » EV-to-Revenue

Nanologica AB (OSTO:NICA) EV-to-Revenue : 11.68 (As of Sep. 21, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Nanologica AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nanologica AB's enterprise value is kr89.11 Mil. Nanologica AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 was kr7.63 Mil. Therefore, Nanologica AB's EV-to-Revenue for today is 11.68.

The historical rank and industry rank for Nanologica AB's EV-to-Revenue or its related term are showing as below:

OSTO:NICA' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.63   Med: 25.05   Max: 250.65
Current: 11.68

During the past 10 years, the highest EV-to-Revenue of Nanologica AB was 250.65. The lowest was 3.63. And the median was 25.05.

OSTO:NICA's EV-to-Revenue is ranked worse than
59% of 1044 companies
in the Biotechnology industry
Industry Median: 7.765 vs OSTO:NICA: 11.68

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-09-21), Nanologica AB's stock price is kr2.33. Nanologica AB's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was kr0.20. Therefore, Nanologica AB's PS Ratio for today is 11.71.


Nanologica AB EV-to-Revenue Historical Data

The historical data trend for Nanologica AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanologica AB EV-to-Revenue Chart

Nanologica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.61 19.66 29.73 190.25 254.01

Nanologica AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 192.88 161.15 254.01 36.92 31.55

Competitive Comparison of Nanologica AB's EV-to-Revenue

For the Biotechnology subindustry, Nanologica AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanologica AB's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanologica AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nanologica AB's EV-to-Revenue falls into.



Nanologica AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nanologica AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=89.105/7.628
=11.68

Nanologica AB's current Enterprise Value is kr89.11 Mil.
Nanologica AB's Revenue for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr7.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanologica AB  (OSTO:NICA) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nanologica AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=2.33/0.199
=11.71

Nanologica AB's share price for today is kr2.33.
Nanologica AB's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanologica AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nanologica AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanologica AB Business Description

Traded in Other Exchanges
N/A
Address
Forskargatan 20G, Södertälje, SWE, SE-151 36
Nanologica AB develops and manufactures nanoporous silica particles for life science applications. It focuses on two areas: Drug Development and Chromatography. The company's drug delivery platforms are NLAB Spiro and NLAB Silica, which aim to produce better medicines for the benefit of patients. Its geographical segments are Sweden, China, the United States, and the Rest of the world.

Nanologica AB Headlines

No Headlines